This review article considers the rising demand for patient-reported outcome measures
(PROMs) in modern ophthalmic research and clinical practice. We review what PROMs are …

Glaucoma is considered to be one of the biggest health problems in the world. It is the main
cause of preventable blindness due to its asymptomatic nature in the early stages on the …

Background Primary open angle glaucoma and ocular hypertension are habitually treated
with eye drops that lower intraocular pressure. Selective laser trabeculoplasty is a safe …

Purpose To report clinical efficacy, predictors of success, and safety of primary selective
laser trabeculoplasty (SLT) used in treatment-naive patients with open-angle glaucoma …

PURPOSE: The LiGHT trial has shown selective laser trabeculoplasty (SLT) to be clinically
and cost-effective as a primary treatment of open-angle glaucoma (OAG) and ocular …

BACKGROUND Newly diagnosed open-angle glaucoma (OAG) and ocular hypertension
(OHT) are habitually treated with intraocular pressure (IOP)-lowering eyedrops. Selective …

Purpose To compare visual field outcomes of ocular hypertensive and glaucoma patients
treated first with medical therapy with those treated first with selective laser trabeculoplasty …

Introduction Vision impairment and eye disease are major global health concerns and have
been associated with increased morbidity and mortality, and lower quality of life. Quality of …

Purpose: The purpose of this study is to evaluate safety and effectiveness of the iStent
infinite Trabecular Micro-Bypass System in patients with OAG uncontrolled by prior surgical …

Purpose To determine the efficacy of repeat selective laser trabeculoplasty (SLT) in
medication-naive open-angle glaucoma (OAG) and ocular hypertensive (OHT) patients …